Wells Fargo execs knew of scam car insurance program for years before it was ended says new lawsuit

According to Reuters, a newly filed lawsuit alleges that four years before the bank ended its scamming auto insurance program, Wells Fargo executives were specifically warned that the bank's fraudulent car insurance program could be overcharging customers. According to the report, a complaint released from seal this week said that executives were briefed in...
Continue reading…

Northrop Grumman pays $27.45 million to end False Claims case alleging inflating hours and invoices on battlefield communications contracts

The Justice Department announced today that Northrop Grumman Systems Corporation (NGSC) has agreed to settle civil allegations that it violated the False Claims Act (FCA), 31 U.S.C. _3729, by overstating the number of hours its employees worked on two battlefield communications contracts with the United States Air Force. Under...
Continue reading…

Emergency room patients given ketamine and antispychotic drugs without their knowledge or consent.

According to an article in STAT https://www.statnews.com/2018/10/29/er-patients-given-ketamine-powerful-drugs-without-consent/?utm_source=STAT+Newsletters&utm_campaign=56d4d18dfb-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-56d4d18dfb-118516237, a Minnesota hospital tested powerful antipsychotics andŒ potent anesthetic on emergency room patients without their knowledge or consent. This is a violation of law say federal inspectors have determined. According to FDA inspectors, the hospital's Institutional Review Board...
Continue reading…

Abbott Labs and Abbvie Inc. pay $25 million to settle with Government on allegations of kickbacks and off label marketing of TriCor

Pharmaceutical companies Abbott Laboratories and AbbVie Inc. (“Abbott”) will pay $25 million to settle federal allegations that it paid kickbacks and unlawfully marketed and promoted the drug TriCor® for: (1) use in treating, preventing, or reducing cardiovascular events and other cardiac health risk; (2) use in combination with statin drugs, and (3) use...
Continue reading…